MARY STEINBACH: Open Payments
NPI 1881958189 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,223 in 44 payments from 8 companies in 2025. Trend: 2023 $61,838 · 2024 $56,426 · 2025 $32,223
Speaker / faculty: $12,562Grant: $7,421Consulting: $6,602Travel & lodging: $5,023Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $12,293 |
| Janssen Biotech, Inc. | 19 | $11,136 |
| GENZYME CORPORATION | 4 | $7,421 |
| Regeneron Pharmaceuticals, Inc. | 1 | $524 |
| Regeneron Healthcare Solutions, Inc. | 1 | $342 |
| Legend Biotech USA Inc. | 1 | $333 |
| Celgene Corporation | 2 | $127 |
| GlaxoSmithKline, LLC. | 1 | $46 |
Products named: RYBREVANT, ELREXFIO, LYNOZYFIC, CARVYKTI, ABECMA, DARZALEX, BLENREP.
Industry payments across UT — which companies pay providers there.
